Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 28, 2019
[Simultaneous Laparoscopic Sigmoid Colectomy and Malignant Lymphoma Biopsy-A Case Report]Noboru Kobayashi, Masakazu Miyake, Mamoru Uemura, et al.
Anticancer Research|November 1, 2023
High Level Sacral Bone Resection for Locally Recurrent Rectal CancerNobuo Takiguchi, Mamoru Uemura, Masatoshi Kitakaze, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 31, 2017
[A Case of GIST of the Stomach with Long-Term Survival after Multidisciplinary Treatment, Including Four Surgical Resections of Liver Metastases]Masatoshi Kitakaze, Motohiro Hirao, Atsushi Miyamoto, et al.
BMC Cancer|August 20, 2024
Postoperative venous thromboembolism after surgery for locally recurrent rectal cancerChikako Kusunoki, Mamoru Uemura, Mao Osaki, et al.
Cells|July 15, 2020
Immuno-Surgical Management of Pancreatic Cancer with Analysis of Cancer ExosomesYu Takeda, Shogo Kobayashi, Masatoshi Kitakaze, et al.
Oncology Letters|June 12, 2025
Clinical and prognostic characteristics of metastatic colorectal cancer with minor <i>RAS</i> mutationsYoshiki Kojitani, Daisuke Sakai, Takatsugu Ogata, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 3, 2024
Survival Impact of Inflammation-based Prognostic Scores in Metastatic or Unresectable Esophageal Cancer Treated With Pembrolizumab Plus ChemotherapyTakahito Sugase, Takashi Kanemura, Tomohira Takeoka, et al.
Oncology|December 5, 2023
Clinical Impact of Early Tumour Shrinkage in Metastatic or Unresectable Oesophageal Cancer Treated with Pembrolizumab plus ChemotherapyTakahito Sugase, Takashi Kanemura, Tomohira Takeoka, et al.
Annals of Surgical Oncology|November 22, 2023
Significance of Comprehensive Analysis of Preoperative Sarcopenia Based on Muscle Mass, Muscle Strength, and Physical Function for the Prognosis of Patients with Esophageal CancerTakashi Kanemura, Tomohira Takeoka, Takahito Sugase, et al.
Anticancer Research|December 30, 2023
Short-term Outcomes of Adjuvant Nivolumab After Neoadjuvant Chemotherapy in Patients With Resected Esophageal Squamous Cell CarcinomaTakahito Sugase, Takashi Kanemura, Tomohira Takeoka, et al.
Pageof 5